Bovine Viral Diarrhea: Virus, Impacts, Control

Bovine viral diarrhea (BVD) represents a major threat to cattle health worldwide, driven by the bovine viral diarrhea virus (BVDV). This pestivirus triggers a spectrum of issues from mild infections to fatal outcomes, primarily through immune suppression that exacerbates other illnesses. Cattle of all ages face risks, but young stock aged 6-24 months suffer the most pronounced effects.

Understanding the BVDV Pathogen

BVDV belongs to the Pestivirus genus within the Flaviviridae family, featuring a single-stranded positive-sense RNA genome. It exists in two biotypes: cytopathic (cp) strains that destroy cells directly and non-cytopathic (ncp) strains that evade immunity more subtly. Genotypes BVDV-1 and BVDV-2 vary in virulence, with type 2 often linked to acute hemorrhagic syndromes. The virus targets epithelial cells in the respiratory and gastrointestinal tracts, lymphoid tissues, and reproductive organs, leading to widespread dissemination via blood and secretions.

Infection begins at mucosal surfaces in the mouth or nose, replicating in tonsils and pharyngeal epithelium before phagocytes carry it to lymph nodes. Viremia peaks 2-4 days post-exposure, persisting 3-10 days in serum and leukocytes. Persistently infected (PI) animals arise from in utero exposure before 120 days of gestation, when the fetal immune system fails to recognize the virus, resulting in lifelong shedding without immunity.

Transmission Dynamics in Herds

BVDV spreads horizontally through direct contact, aerosols, semen, milk, urine, feces, and contaminated equipment. PI animals are super-shedders, releasing 1,000 times more virus than transiently infected ones, maintaining herd reservoirs for weeks in environments. Vertical transmission occurs when pregnant dams infect fetuses, producing PI calves in over 90% of cases from naive mothers.

• Direct nose-to-nose contact among cattle.
• Shared feed, water, or bedding contaminated by secretions.
• Breeding via infected semen or embryonic transfer.
• Indirect via fomites like needles or trailers.

Transiently infected animals clear the virus in weeks, but PI carriers remain asymptomatic yet highly contagious, often appearing normal until stressed.

Clinical Manifestations Across Age Groups

Symptoms vary by strain, host immunity, and timing. Subclinical cases dominate, but acute outbreaks feature high fever (41-42°C), depression, anorexia, and milk yield drops. Diarrhea, though named in the disease, stems from immunosuppression enabling secondary bacterial invasions rather than primary gut damage.

Severe type 2 infections cause platelet drops, leading to petechiae on mucous membranes, prolonged bleeding, and coronary band erosions. Lymphoid depletion and serosal hemorrhages mark necropsies.

Reproductive and Persistent Infection Consequences

Early gestation exposure (days 40-120) yields PI calves, immunotolerant and virus-positive for life. These animals grow poorly, show neurological defects like blindness or ataxia, and serve as amplifiers. Later infections cause embryonic death, mummification, or abortions. PI heifers perpetuate the cycle by birthing PI offspring.

Mucosal disease (MD), a late-stage catastrophe, afflicts PI cattle superinfected with cp BVDV. It manifests as fever, sanguinous diarrhea, oral/nasal ulcers, and hoof lesions, culminating in death within 3 weeks from gut necrosis and sepsis. Necropsies reveal epithelial erosions, lymphoid necrosis, and mucosal shreds in feces.

Diagnostic Approaches for Confirmation

Diagnosis integrates history, signs, and lab tests. PCR detects viral RNA in ear notches, blood, or tissues with high sensitivity. Virus isolation from serum confirms active shedding. Serology via ELISA measures antibodies, distinguishing naive, transiently infected, or PI animals (negative antibody despite viremia).

1. Ear notch antigen ELISA for PI screening (pool testing herds).
2. Whole blood PCR for acute cases.
3. Paired sera for seroconversion.
4. Histopathology for MD confirmation.

PI testing targets newborns from unvaccinated dams; positives warrant immediate isolation and removal.

Management and Supportive Therapies

No specific antiviral exists; care focuses on fluids, electrolytes, and antibiotics for secondary infections. Isolate cases, provide NSAIDs for fever/pain, and ensure nutrition. Mortality in acute cases drops with prompt intervention, but PI and MD remain lethal.

Prevention Strategies: Biosecurity and Vaccination

Eradication hinges on PI elimination via testing/culling, biosecurity, and vaccination. Modified-live vaccines induce mucosal immunity, reducing PI births by 75-90%, while killed vaccines suit pregnant stock.

• PI Control: Test all calves at weaning; cull positives.
• Biosecurity: Quarantine newcomers 21-30 days, sanitize equipment.
• Vaccination: Annual boosters pre-breeding; maternal antibodies protect neonates.
• Herd Monitoring: Sentinel serology tracks exposure.

National programs in Europe mandate PI removal, slashing prevalence.

Frequently Asked Questions (FAQs)

What causes bovine viral diarrhea in cattle?

BVDV, a pestivirus, causes it through immunosuppression and direct tissue damage.

How do I identify persistently infected animals?

Use ear notch ELISA or PCR; they test virus-positive but antibody-negative.

Can BVDV affect other species?

Primarily cattle, but sheep, goats, and bison can harbor it.

Is vaccination 100% effective against BVD?

No, but it drastically cuts clinical disease and PI risks when combined with biosecurity.

What are economic impacts of BVD outbreaks?

Losses from mortality, reduced milk/meat, infertility total billions annually worldwide.

Global Perspectives and Eradication Efforts

BVDV burdens dairy/beef industries with infertility, respiratory complexes like “shipping fever,” and chronic underperformance. Scandinavia nears eradication via compulsory reporting and culling. U.S. voluntary programs emphasize PI screening. Producers must integrate testing (cost ~$3/head) with vaccines for ROI via healthier herds.

In summary, proactive surveillance transforms BVD from herd destroyer to manageable foe. Regular PI hunts, closed herds, and strategic immunization safeguard futures.